KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Resmed (RMD) Restructuring Costs (2017 - 2025)

Historic Restructuring Costs for Resmed (RMD) over the last 9 years, with Q4 2025 value amounting to $5.9 million.

  • Resmed's Restructuring Costs changed N/A to $5.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $23.8 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2025, which is 9683.78% down from last year.
  • Latest data reveals that Resmed reported Restructuring Costs of $5.9 million as of Q4 2025.
  • In the past 5 years, Resmed's Restructuring Costs registered a high of $64.2 million during Q4 2023, and its lowest value of $1.8 million during Q2 2023.
  • Moreover, its 3-year median value for Restructuring Costs was $5.9 million (2025), whereas its average is $14.3 million.
  • Over the last 5 years, Resmed's Restructuring Costs had its largest YoY gain of 66352.83% in 2023, and its largest YoY loss of 568.42% in 2023.
  • Quarter analysis of 3 years shows Resmed's Restructuring Costs stood at $8.4 million in 2022, then surged by 663.53% to $64.2 million in 2023, then plummeted by 90.76% to $5.9 million in 2025.
  • Its Restructuring Costs was $5.9 million in Q4 2025, compared to $15.8 million in Q3 2025 and $2.0 million in Q2 2025.